Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes

American Journal of Tropical Medicine and Hygiene

Volumn 77, Issue 3, 2007, Pages 438-443

  Méndez, Fabián ^a   Herrera, Sócrates ^b   Murrain, Bermans ^b   Gutiérrez, Andrés ^b   Moreno, Luz A ^b   Manzano, María ^c   Muñoz, Álvaro ^d   Plowe, Christopher V ^e  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b Malaria Vacc and Drug Test Center   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR; ANTIMALARIAL AGENT; FOLIC ACID ANTAGONIST; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANOPHELES; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GAMETOCYTE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PREVALENCE; TREATMENT RESPONSE; ANIMAL; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; ENZYMOLOGY; GENETIC SELECTION; GENETICS; PARASITOLOGY; PHYSIOLOGY; POINT MUTATION; RISK;

ANOPHELES (GENUS); PLASMODIUM FALCIPARUM;

ANIMALS; ANOPHELES; ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; FOLIC ACID ANTAGONISTS; HUMANS; MALARIA, FALCIPARUM; ODDS RATIO; PLASMODIUM FALCIPARUM; POINT MUTATION; PYRIMETHAMINE; SELECTION (GENETICS); SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 35748953756     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.77.438     Document Type: Article

References (20)

1. Méndez F, Muñoz A, Carrasquilla G, Jurado D, Arévalo-Herrera M, Cortese JF, Plowe CV, 2002. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol 156: 230-238.
2. Morrow RH, 2001. The epidemiology and control of malaria. Nelson KE, Williams CM, Graham NM, eds. Infectious Disease Epidemiology: Theory and Practice. Gaithersburg, MD: Aspen Publishers, 675-710.
3. Bishop A, 1954. The effect of sulphadiazine, proguanil and 2:4-diamino-6:7diisopropylpteridine upon gametocyte production in Plasmodium gallinaceum. Parasitology 45: 163-185.
4. Sucharit S, Surathin K, Tumrasvin W, Sucharit P, 1977. Chloroquine resistant Plasmodium falciparum in Thailand: susceptibility to Anopheles. J Med Assoc Thai 60: 648-654.
5. Sutherland C, Alloueche A, Curtis J, Drakeley CJ, Ord R, Durainsingh M, Greenwood BM, Pinder M, Warhust D, Targett GA, 2002. Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. Am J Trop Med Hyg 67: 578-585.
6. Espinal LS, 1968. Visión Ecológica del Departamento del Valle del Cauca. Valle, Colombia: Ed. Universidad del Valle. 1968.
7. Méndez F, Carrasquilla G, Muñoz A, 2000. Risk factors associated with malaria infection in an urban setting. Trans R Soc Trop Med Hyg 94: 367-371.
8. Olano V, Carrasquilla G, Mendez F, 1997. Transmission of urban malaria in Buenaventura, Colombia: entomological features. Pan Am J Public Health 1: 287-294.
9. Quiñónez ML, Suarez MF, Fleming GA, 1987. Distribución y bionomía de los anofelinos de la costa Pacifica colombiana. Colomb Med 18: 19-24.
10. World Health Organization, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated falciparum Malaria. Geneva: World Health Organization. Technical Document 2003. WHO/HTM/RBM/2003.50.
11. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK, 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of sulfadoxine-pyrimethamine use and resistance. J Infect Dis 176: 1590-1596.
12. Hurtado S, Salas ML, Romero JF, Zapata JC, Ortiz H, Arévalo- Herrera M, Herrera S, 1997. Regular production of infective sporozoites of Plasmodium falciparum and P. vivax in laboratory-bred Anopheles albimanus. Ann Trop Med Parasitol 91: 4.
13. Hallett RL, Dunyo S, Ord R, Jawara M, Pinder M, Randall A, Alloueche A, Walraven G, Targett G, Alexander N, Sutherland CJ, 2006, Chloroquine/ sulphadoxine-pyrimethamine for Gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparum. PLoS Clin Trials 1: e15.
14. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV, 2002. Molecular markers for failure of sulfadoxinepyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 185: 380-388.
15. Clyde DF, 1966. Drug resistance of malaria parasites in Tanzania. East Afr Med J 43: 405-408.
16. Clyde DF, Shute GT, 1957. Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. Trans R Soc Trop Med Hyg 51: 505-513.
17. Peterson DS, Walliker D, Wellems TE, 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci U S A 85: 9114-9118.
18. Cortese JF, Caraballo A, Contreras CE, Plowe CV, 2002. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis 186: 999-1006.
19. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T, 2004. Intercontinental spread of pyrimethamine-resistant malaria. Science 305: 1124.
20. Hastings IM, 2004. The origins of antimalarial drug resistance. Trends Parasitol 20: 512-518.